Cost-effectiveness of Artificial Intelligence-Based Retinopathy of Prematurity Screening.

ABSTRACT:

Importance

Artificial intelligence (AI)-based retinopathy of prematurity (ROP) screening may improve ROP care, but its cost-effectiveness is unknown.

Objective

To evaluate the relative cost-effectiveness of autonomous and assistive AI-based ROP screening compared with telemedicine and ophthalmoscopic screening over a range of estimated probabilities, costs, and outcomes.

Design, setting, and participants

A cost-effectiveness analysis of AI ROP screening compared with ophthalmoscopy and telemedicine via economic modeling was conducted. Decision trees created and analyzed modeled outcomes and costs of 4 possible ROP screening strategies: ophthalmoscopy, telemedicine, assistive AI with telemedicine review, and autonomous AI with only positive screen results reviewed. A t

SUBMITTER: Morrison SL 

PROVIDER: S-EPMC8931675 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature